PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression

被引:0
作者
Heleen M de Vogel-van den Bosch
Meike Bünger
Philip J de Groot
Hanneke Bosch-Vermeulen
Guido JEJ Hooiveld
Michael Müller
机构
[1] Wageningen University,Nutrition, Metabolism and Genomics group, Division of Human Nutrition
[2] TI Food and Nutrition,Nutrigenomics Consortium
来源
BMC Genomics | / 9卷
关键词
Oleic Acid; Intestinal Motility; WY14643; Barrier Gene; Oleic Acid Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 542 条
[1]  
Hediger MA(2004)The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins Pflugers Arch 447 465-468
[2]  
Romero MF(2002)Mammalian ABC transporters in health and disease Annu Rev Biochem 71 537-592
[3]  
Peng JB(2001)Active secretion and enterocytic drug metabolism barriers to drug absorption Adv Drug Deliv Rev 46 89-102
[4]  
Rolfs A(2003)The small intestine as a xenobiotic-metabolizing organ Drug Metab Dispos 31 1520-1525
[5]  
Takanaga H(2002)The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans Curr Drug Metab 3 561-597
[6]  
Bruford EA(2000)Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens Curr Drug Metab 1 1-30
[7]  
Borst P(1997)Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes FASEB J 11 3-14
[8]  
Elferink RO(2000)Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease Annual Review of Pharmacology and Toxicology 40 581-616
[9]  
Wacher VJ(1999)GST function in drug and stress response Drug Resistance Updates 2 143-170
[10]  
Salphati L(1993)Glutathione-related enzymes, glutathione and multidrug resistance Cytotechnology 12 155-17